Literature DB >> 11338174

Phenytoin inhibits isolation-induced aggression specifically in rats with low serotonin.

N B Keele1.   

Abstract

Phenytoin is a widely used anticonvulsant drug that also reduces aggressive behavior. Aggression in humans and animals is often associated with low serotonin levels. This study examined the anti-aggressive properties of phenytoin in rodent isolation-induced aggression using a resident-intruder test to quantify aggression. Chronic treatment with p-chlorophenyl-alanine (PCPA), a competitive inhibitor of serotonin synthesis, significantly enhanced resident attack behavior compared to saline-treated control rats. Phenytoin dose-dependently reduced aggressive behavior specifically in PCPA-treated rats, but had no anti-aggressive properties in saline-treated rats. These data suggest that aggressive behavior in this model may be related to neuronal hyperexcitability that is sensitive to the anticonvulsant effects of phenytoin. Further, these data suggest isolation-induced aggression in PCPA-treated rats may be a useful model to investigate aggression associated with low serotonin in the brain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11338174     DOI: 10.1097/00001756-200105080-00012

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  4 in total

1.  Phenytoin normalizes exaggerated fear behavior in p-chlorophenylalanine (PCPA)-treated rats.

Authors:  Cathryn R Hughes; N Bradley Keele
Journal:  Epilepsy Behav       Date:  2006-10-12       Impact factor: 2.937

2.  P-chlorophenylalanine increases glutamate receptor 1 transcription in rat amygdala.

Authors:  Lee Tran; N Bradley Keele
Journal:  Neuroreport       Date:  2011-10-26       Impact factor: 1.837

3.  Animal violence demystified.

Authors:  Deepa Natarajan; Doretta Caramaschi
Journal:  Front Behav Neurosci       Date:  2010-04-05       Impact factor: 3.558

4.  Depletion of serotonin in the basolateral amygdala elevates glutamate receptors and facilitates fear-potentiated startle.

Authors:  L Tran; B K Lasher; K A Young; N B Keele
Journal:  Transl Psychiatry       Date:  2013-09-03       Impact factor: 6.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.